Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.

[1]  D. Vohora,et al.  Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy , 2015, Expert opinion on drug delivery.

[2]  S. Talegaonkar,et al.  Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. , 2014, International journal of pharmaceutics.

[3]  V. Patravale,et al.  Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. , 2013, International journal of pharmaceutics.

[4]  Lin Zhao,et al.  Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations. , 2013, International journal of pharmaceutics.

[5]  Choo Yuen May,et al.  An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. , 2011, Colloids and surfaces. B, Biointerfaces.

[6]  K. Pathak,et al.  Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. , 2011, International journal of pharmaceutics.

[7]  Qi Shen,et al.  Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Xiaoning Zhang,et al.  Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. , 2010, International journal of pharmaceutics.

[9]  Mushir M. Ali,et al.  Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. , 2010, Colloids and surfaces. B, Biointerfaces.

[10]  Bradley D Anderson,et al.  What determines drug solubility in lipid vehicles: is it predictable? , 2008, Advanced drug delivery reviews.

[11]  V. Patravale,et al.  Nanostructured lipid carrier (NLC) based gel of celecoxib. , 2008, International journal of pharmaceutics.

[12]  H. Nair,et al.  Design and Evaluation of Self-Microemulsifying Drug Delivery System (SMEDDS) of Tacrolimus , 2008, AAPS PharmSciTech.

[13]  J. Pardeike,et al.  Nanostructured lipid carriers (NLC) in cosmetic dermal products. , 2007, Advanced drug delivery reviews.

[14]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[15]  M. Üner.  Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. , 2006, Die Pharmazie.

[16]  R. Müller,et al.  Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC , 2006, Journal of microencapsulation.

[17]  V. Patravale,et al.  Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib , 2006, Drug development and industrial pharmacy.

[18]  Y. Kawashima,et al.  A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[19]  H. Kristensen,et al.  Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  Ben J Boyd,et al.  Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. , 2004, Journal of pharmaceutical sciences.

[21]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[22]  Atsuo Ohike,et al.  Establishment of new preparation method for solid dispersion formulation of tacrolimus. , 2003, International journal of pharmaceutics.

[23]  R. Müller,et al.  Nanostructured lipid matrices for improved microencapsulation of drugs. , 2002, International journal of pharmaceutics.

[24]  P. Tso,et al.  An examination of the factors affecting intestinal lymphatic transport of dietary lipids. , 2001, Advanced drug delivery reviews.

[25]  C. Larsen,et al.  Addition of hydrogen bond donating excipients to oil solution: effect on in vitro drug release rate and viscosity. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  F. Hirayama,et al.  Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. , 2001, Journal of pharmaceutical sciences.

[27]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[28]  Vivian Charles McAlister,et al.  Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity. , 1999, Transplantation proceedings.

[29]  K. Goa,et al.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. , 1997, Drugs.

[30]  R. Kershner,et al.  Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. , 1996, Transplantation.

[31]  A. Thomson,et al.  Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. , 1993, Canadian journal of physiology and pharmacology.

[32]  J. Reymond,et al.  In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles , 1988, Pharmaceutical Research.

[33]  M. Kobayashi,et al.  The oral dosage form of FK-506. , 1987, Transplantation proceedings.

[34]  C. Staatz,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation , 2004, Clinical pharmacokinetics.